Responses
Clinical/translational cancer immunotherapy
Original research
Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
